Name: Sleep Software Market by Function (Sleep Tracking, Analysis, Disorder Management, Improvement), Indication (Insomnia, Sleep Apnea), Offering (Platforms, Apps (Mobile)), End-user (Providers, Individual), Deployment, Type, & Region - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: HIT9280
Price: 4950 USD
Availability: InStock

1 INTRODUCTION 29 1.1 STUDY OBJECTIVES 29 1.2 MARKET DEFINITION 29 1.3 MARKET SCOPE 30 1.3.1 MARKET SEGMENTATION 30 1.3.2 INCLUSIONS & EXCLUSIONS 31 1.3.3 YEARS CONSIDERED 32 1.3.4 CURRENCY CONSIDERED 32 1.4 MARKET STAKEHOLDERS 33 2 RESEARCH METHODOLOGY 34 2.1 RESEARCH DATA 34 2.1.1 SECONDARY DATA 35 2.1.1.1 Key data from secondary sources 36 2.1.2 PRIMARY DATA 36 2.1.2.1 Key industry insights 38 2.2 MARKET ESTIMATION METHODOLOGY 39 2.3 MARKET SIZE ESTIMATION 39 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 45 2.5 RESEARCH ASSUMPTIONS 46 2.5.1 MARKET SIZING ASSUMPTIONS 46 2.5.2 OVERALL STUDY ASSUMPTIONS 46 2.6 RISK ASSESSMENT 47 2.7 RESEARCH LIMITATIONS 47 2.7.1 METHODOLOGY-RELATED LIMITATIONS 47 2.7.2 SCOPE-RELATED LIMITATIONS 47 3 EXECUTIVE SUMMARY 48 4 PREMIUM INSIGHTS 54 4.1 SLEEP SOFTWARE MARKET OVERVIEW 54 4.2 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY END USER & REGION 55 4.3 SLEEP SOFTWARE MARKET: GEOGRAPHIC MIX 56 4.4 SLEEP SOFTWARE MARKET: DEVELOPED VS. EMERGING ECONOMIES 56 5 MARKET OVERVIEW 57 5.1 INTRODUCTION 57 5.2 MARKET DYNAMICS 57 5.2.1 DRIVERS 59 5.2.1.1 Expansion of telehealth and remote patient monitoring 59 5.2.1.2 Vast population of undiagnosed sleep apnea patients 59 5.2.1.3 Growing awareness regarding sleep apnea and wellness improvement 61 5.2.1.4 Favorable reimbursement and financial aid for sleep apnea devices and therapies 62 5.2.1.5 Increasing emphasis on corporate wellness programs 62 5.2.2 RESTRAINTS 63 5.2.2.1 Data privacy and security concerns 63 5.2.2.2 Use of alternative therapies and medications for sleep disorders 66 5.2.2.3 Resistance from traditional healthcare providers 67 5.2.3 OPPORTUNITIES 68 5.2.3.1 Development of mHealth tools 68 5.2.3.2 Rising potential of AI & ML in sleep medicine 69 5.2.3.3 Rising demand for smart wearables 70 5.2.3.4 Increasing focus on mental health and wellbeing 70 5.2.4 CHALLENGES 71 5.2.4.1 Lack of clinical validation of sleep apps 71 5.2.4.2 Strategic challenges in monetizing sleep apps 71 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72 5.4 INDUSTRY TRENDS 72 5.4.1 VALUE-BASED CARE MODELS 72 5.4.2 CLOUD-BASED SOLUTIONS 73 5.4.3 IOT AND WEARABLES 73 5.5 ECOSYSTEM ANALYSIS 74 5.6 SUPPLY CHAIN ANALYSIS 77 5.7 TECHNOLOGY ANALYSIS 78 5.7.1 KEY TECHNOLOGIES 78 5.7.1.1 Artificial intelligence & machine learning 79 5.7.1.2 Internet of things (IoT) 79 5.7.1.3 Mobile applications 79 5.7.1.4 Biosensors and wearable technology 80 5.7.1.5 Gamification technology 80 5.7.1.6 Voice assistants 81 5.7.2 COMPLEMENTARY TECHNOLOGIES 81 5.7.2.1 Smart home automation 81 5.7.2.2 Telemedicine platforms 81 5.7.2.3 Data analysis and visualization tools 82 5.7.2.4 EHR integration 82 5.7.2.5 Cloud computing 83 5.7.3 ADJACENT TECHNOLOGIES 83 5.7.3.1 Fitness trackers 83 5.7.3.2 Respiratory monitoring devices 83 5.7.3.3 Augmented reality (AR) & virtual reality (VR) 84 5.8 REGULATORY ANALYSIS 84 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 5.8.2 REGULATORY SCENARIO 87 5.8.2.1 North America 87 5.8.2.2 Europe 89 5.8.2.3 Asia Pacific 89 5.8.2.4 Middle East & Africa 91 5.8.2.5 Latin America 91 5.9 PRICING ANALYSIS 91 5.9.1 AVERAGE SELLING PRICE OF SLEEP APPS, BY KEY PLAYER (2023) 92 5.9.2 AVERAGE SELLING PRICE OF SLEEP APPS, BY REGION (2023) 93 5.10 PORTER’S FIVE FORCES ANALYSIS 94 5.10.1 INTENSITY OF COMPETITIVE RIVALRY 95 5.10.2 BARGAINING POWER OF BUYERS 95 5.10.3 THREAT OF SUBSTITUTES 95 5.10.4 THREAT OF NEW ENTRANTS 95 5.10.5 BARGAINING POWER OF SUPPLIERS 95 5.11 PATENT ANALYSIS 96 5.11.1 PATENT PUBLICATION TRENDS 96 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE 97 5.11.3 MAJOR PATENTS IN SLEEP SOFTWARE MARKET 98 5.12 KEY STAKEHOLDERS & BUYING CRITERIA 100 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 100 5.12.2 KEY BUYING CRITERIA 101 5.13 END-USER ANALYSIS 102 5.13.1 UNMET NEEDS 102 5.13.2 END-USER EXPECTATIONS 103 5.14 KEY CONFERENCES & EVENTS, 2025–2026 104 5.15 CASE STUDY ANALYSIS 105 5.15.1 CASE STUDY 1: TRANSFORMING SLEEP STUDY AT ST. LUKE’S SLEEP MEDICINE INSTITUTE 105 5.15.2 CASE STUDY 2: GRANGER MEDICAL CLINIC’S PATH TO EFFICIENT HEALTHCARE OPERATIONS 106 5.16 INVESTMENT & FUNDING SCENARIO 106 5.17 BUSINESS MODEL ANALYSIS 107 5.18 IMPACT OF AI/GEN AI ON SLEEP SOFTWARE MARKET 107 5.18.1 KEY USE CASES 108 5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 109 5.18.2.1 Case study 1: Leveraging AI to drive improved patient adherence and operational efficiency at Aeroflow Sleep 109 5.18.2.2 Case study 2: Optimizing sleep lab workflow and enhancing patient care with EnsoSleep AI at Northwell Health 110 5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 111 5.18.3.1 Remote patient monitoring market 111 5.18.3.2 Digital health market 111 5.18.3.3 Telehealth and telemedicine market 112 5.18.3.4 mHealth market 112 5.18.4 USER READINESS AND IMPACT ASSESSMENT 112 5.18.4.1 User readiness 112 5.18.4.1.1 User A: Individual users 112 5.18.4.1.2 User B: Healthcare providers 112 5.18.4.2 Impact assessment 113 5.18.4.2.1 User A: Individual users 113 5.18.4.2.2 User B: Healthcare providers 113 6 SLEEP SOFTWARE MARKET, BY TYPE 115 6.1 INTRODUCTION 116 6.2 INTEGRATED SOFTWARE 116 6.2.1 NEED FOR INTEGRATED SOFTWARE WITHIN BROADER HEALTH AND WELLNESS ECOSYSTEMS TO BOLSTER GROWTH 116 6.3 STANDALONE SOFTWARE 117 6.3.1 RISING TREND TOWARD MOBILE HEALTH APPLICATIONS TO INTENSIFY GROWTH 117 7 SLEEP SOFTWARE MARKET, BY OFFERING 119 7.1 INTRODUCTION 120 7.2 PLATFORMS 120 7.2.1 GROWING ADOPTION OF CONNECTED HEALTH TECHNOLOGIES TO BOOST MARKET 120 7.3 APPLICATIONS 121 7.3.1 MOBILE APPLICATIONS 122 7.3.1.1 Increasing penetration of smartphones and consumer demand for on-the-go health monitoring tools to aid growth 122 7.3.2 DESKTOP APPLICATIONS 123 7.3.2.1 Need for advanced solutions to address sleep issues and improve sleep quality to expedite growth 123 8 SLEEP SOFTWARE MARKET, BY FUNCTION 125 8.1 INTRODUCTION 126 8.2 SLEEP TRACKING 126 8.2.1 RISING HEALTH AWARENESS ABOUT IMPORTANCE OF SLEEP TO FACILITATE GROWTH 126 8.3 SLEEP IMPROVEMENT 127 8.3.1 INCREASING PREFERENCE FOR NON-INVASIVE SOLUTIONS FOR SLEEP IMPROVEMENT TO FAVOR GROWTH 127 8.4 SLEEP ANALYSIS 128 8.4.1 GROWING INTEGRATION OF SLEEP ANALYSIS TOOLS INTO WEARABLES TO FUEL MARKET 128 8.5 SLEEP DISORDER MANAGEMENT 129 8.5.1 INCREASING RESEARCH ON SLEEP DISORDER DIAGNOSTICS TO SUPPORT GROWTH 129 9 SLEEP SOFTWARE MARKET, BY INDICATION 131 9.1 INTRODUCTION 132 9.2 INSOMNIA 132 9.2.1 RISING MENTAL HEALTH ISSUES AND DEMAND FOR NON-PHARMACOLOGICAL TREATMENTS TO AID GROWTH 132 9.3 SLEEP APNEA 133 9.3.1 GROWING PATIENT SHIFT TO DIGITAL SOLUTIONS TO BOOST MARKET 133 9.4 GENERAL SLEEP IMPROVEMENT 134 9.4.1 RISE IN HEALTH CONSCIOUSNESS AMONG CONSUMERS TO AUGMENT GROWTH 134 9.5 OTHER INDICATIONS 136 10 SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL 137 10.1 INTRODUCTION 138 10.2 ON-PREMISE MODELS 138 10.2.1 NEED FOR ENHANCED DATA CONTROL, SECURITY, AND COMPLIANCE TO PROMOTE GROWTH 138 10.3 CLOUD-BASED MODELS 139 10.3.1 GROWING ADOPTION OF REMOTE PATIENT MONITORING SYSTEMS TO DRIVE MARKET 139 11 SLEEP SOFTWARE MARKET, BY END USER 141 11.1 INTRODUCTION 142 11.2 INDIVIDUAL USERS 142 11.2.1 GROWING AWARENESS OF SLEEP HEALTH AND ADOPTION OF WEARABLE TRACKERS TO PROPEL MARKET 142 11.3 HEALTHCARE PROVIDERS 143 11.3.1 RISING TECHNOLOGICAL ADVANCEMENTS IN SLEEP SOFTWARE TO DRIVE MARKET 143 11.4 OTHER END USERS 144 12 SLEEP SOFTWARE MARKET, BY REGION 145 12.1 INTRODUCTION 146 12.2 NORTH AMERICA 146 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 147 12.2.2 US 150 12.2.2.1 Increasing investments due to reduced workplace productivity and decreased quality of life to drive market 150 12.2.3 CANADA 153 12.2.3.1 Government investments and increasing awareness to drive market 153 12.3 EUROPE 156 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 156 12.3.2 GERMANY 159 12.3.2.1 Growing need for effective diagnostic and treatment solutions to drive market 159 12.3.3 UK 162 12.3.3.1 Rising interest in sleep management apps to favor market 162 12.3.4 FRANCE 164 12.3.4.1 Rising awareness and supportive government initiatives to fuel market growth 164 12.3.5 ITALY 167 12.3.5.1 Growing insomnia prevalence in Italy to propel market 167 12.3.6 SPAIN 170 12.3.6.1 Increasing incidence of sleep problems in younger populations to drive demand 170 12.3.7 REST OF EUROPE 172 12.4 ASIA PACIFIC 175 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 175 12.4.2 CHINA 179 12.4.2.1 Rising sleep disorder prevalence to drive market 179 12.4.3 INDIA 182 12.4.3.1 Collaborative efforts with other countries to support market growth 182 12.4.4 JAPAN 185 12.4.4.1 Need for digital solutions and government initiatives to drive market 185 12.4.5 REST OF ASIA PACIFIC 187 12.5 LATIN AMERICA 190 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 190 12.5.2 BRAZIL 193 12.5.2.1 Rising cases of sleep disorders among older adults to drive market 193 12.5.3 MEXICO 196 12.5.3.1 Socioeconomic factors and environmental stressors to support market growth 196 12.5.4 REST OF LATIN AMERICA 198 12.6 MIDDLE EAST & AFRICA 201 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 201 12.6.2 GCC COUNTRIES 204 12.6.2.1 Rising obesity rate to drive demand for sleep disorder treatment solutions in GCC countries 204 12.6.3 REST OF MIDDLE EAST & AFRICA 207 13 COMPETITIVE LANDSCAPE 210 13.1 INTRODUCTION 210 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 210 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP SOFTWARE MARKET 210 13.3 REVENUE ANALYSIS, 2019–2023 212 13.4 MARKET SHARE ANALYSIS, 2023 213 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 216 13.5.1 STARS 216 13.5.2 EMERGING LEADERS 216 13.5.3 PERVASIVE PLAYERS 217 13.5.4 PARTICIPANTS 217 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 218 13.5.5.1 Company footprint 218 13.5.5.2 Region footprint 219 13.5.5.3 Type footprint 220 13.5.5.4 Offering footprint 221 13.5.5.5 Function footprint 222 13.5.5.6 Indication footprint 223 13.5.5.7 Deployment footprint 224 13.5.5.8 End-user footprint 225 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 226 13.6.1 PROGRESSIVE COMPANIES 226 13.6.2 RESPONSIVE COMPANIES 226 13.6.3 DYNAMIC COMPANIES 226 13.6.4 STARTING BLOCKS 226 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 228 13.6.5.1 Detailed list of key startups/SMEs 228 13.6.5.2 Competitive benchmarking of key startups/SMEs 229 13.7 COMPANY VALUATION & FINANCIAL METRICS 229 13.8 BRAND/SOFTWARE COMPARISON 231 13.9 COMPETITIVE SCENARIO 232 13.9.1 PRODUCT LAUNCHES & ENHANCEMENTS 232 13.9.2 DEALS 232 13.9.3 EXPANSIONS 233 13.9.4 OTHER DEVELOPMENTS 234 14 COMPANY PROFILES 235 14.1 KEY PLAYERS 235 14.1.1 CALM 235 14.1.1.1 Business overview 235 14.1.1.2 Solutions offered 236 14.1.1.3 Recent developments 236 14.1.1.3.1 Deals 236 14.1.1.4 MnM view 237 14.1.1.4.1 Right to win 237 14.1.1.4.2 Strategic choices 237 14.1.1.4.3 Weaknesses & competitive threats 237 14.1.2 HEADSPACE INC. 238 14.1.2.1 Business overview 238 14.1.2.2 Solutions offered 238 14.1.2.3 Recent developments 239 14.1.2.3.1 Product launches 239 14.1.2.3.2 Deals 239 14.1.2.3.3 Other developments 240 14.1.2.4 MnM view 240 14.1.2.4.1 Right to win 240 14.1.2.4.2 Strategic choices 240 14.1.2.4.3 Weaknesses & competitive threats 240 14.1.3 RESMED 241 14.1.3.1 Business overview 241 14.1.3.2 Solutions offered 242 14.1.3.3 Recent developments 243 14.1.3.3.1 Product enhancements 243 14.1.3.3.2 Deals 244 14.1.3.3.3 Expansions 245 14.1.3.4 MnM view 245 14.1.3.4.1 Right to win 245 14.1.3.4.2 Strategic choices 245 14.1.3.4.3 Weaknesses & competitive threats 245 14.1.4 KONINKLIJKE PHILIPS N.V. 246 14.1.4.1 Business overview 246 14.1.4.2 Solutions offered 248 14.1.4.3 MnM view 249 14.1.4.3.1 Right to win 249 14.1.4.3.2 Strategic choices 249 14.1.4.3.3 Weaknesses & competitive threats 249 14.1.5 INSPIRE MEDICAL SYSTEMS, INC. 250 14.1.5.1 Business overview 250 14.1.5.2 Solutions offered 251 14.1.5.3 MnM view 251 14.1.5.3.1 Right to win 251 14.1.5.3.2 Strategic choices 251 14.1.5.3.3 Weaknesses & competitive threats 251 14.1.6 CADWELL INDUSTRIES INC. 252 14.1.6.1 Business overview 252 14.1.6.2 Solutions offered 252 14.1.6.3 Recent developments 253 14.1.6.3.1 Deals 253 14.1.7 COMPUMEDICS LIMITED 254 14.1.7.1 Business overview 254 14.1.7.2 Solutions offered 255 14.1.8 NEUROVIRTUAL 256 14.1.8.1 Business overview 256 14.1.8.2 Solutions offered 256 14.1.8.3 Recent developments 257 14.1.8.3.1 Expansions 257 14.1.9 NIHON KOHDEN CORPORATION 258 14.1.9.1 Business overview 258 14.1.9.2 Solutions offered 259 14.1.9.3 Recent developments 260 14.1.9.3.1 Deals 260 14.1.9.3.2 Expansions 260 14.1.10 NOX MEDICAL 261 14.1.10.1 Business overview 261 14.1.10.2 Solutions offered 261 14.1.10.3 Recent developments 262 14.1.10.3.1 Product launches & enhancements 262 14.1.11 NATUS MEDICAL INCORPORATED 263 14.1.11.1 Business overview 263 14.1.11.2 Solutions offered 263 14.1.11.3 Recent developments 264 14.1.11.3.1 Deals 264 14.1.12 RXNT 265 14.1.12.1 Business overview 265 14.1.12.2 Solutions offered 265 14.1.12.3 Recent developments 266 14.1.12.3.1 Product launches 266 14.1.13 CLEVELAND MEDICAL DEVICES INC. 267 14.1.13.1 Business overview 267 14.1.13.2 Solutions offered 267 14.1.13.3 Recent developments 268 14.1.13.3.1 Product enhancements 268 14.1.14 SOMNOMEDICS AG 269 14.1.14.1 Business overview 269 14.1.14.2 Solutions offered 269 14.1.14.3 Recent developments 270 14.1.14.3.1 Deals 270 14.1.15 CIDELEC 271 14.1.15.1 Business overview 271 14.1.15.2 Solutions offered 271 14.1.16 SLEEP CYCLE 272 14.1.16.1 Business overview 272 14.1.16.2 Solutions offered 273 14.1.16.3 Recent developments 273 14.1.16.3.1 Product launches 273 14.1.16.3.2 Deals 274 14.1.17 LÖWENSTEIN MEDICAL SE & CO. KG 275 14.1.17.1 Business overview 275 14.1.17.2 Solutions offered 275 14.1.18 CAMNTECH LTD. 277 14.1.18.1 Business overview 277 14.1.18.2 Solutions offered 277 14.1.18.3 Recent developments 278 14.1.18.3.1 Product launches 278 14.1.19 FISHER & PAYKEL HEALTHCARE LIMITED 279 14.1.19.1 Business overview 279 14.1.19.2 Solutions offered 280 14.1.19.3 Recent developments 281 14.1.19.3.1 Product launches 281 14.1.19.3.2 Expansions 281 14.1.20 BIOSERENITY 282 14.1.20.1 Business overview 282 14.1.20.2 Solutions offered 282 14.1.20.3 Recent developments 283 14.1.20.3.1 Other developments 283 14.1.21 VYAIRE MEDICAL, INC. 284 14.1.21.1 Business overview 284 14.1.21.2 Solutions offered 284 14.2 OTHER PLAYERS 285 14.2.1 HONEYNAPS 285 14.2.2 SLEEPIMAGE 286 14.2.3 SLEEP RESET 287 14.2.4 BIGHEALTH 288 14.2.5 BODYMATTER, INC. 289 14.2.6 NEYBOX DIGITAL LTD. 289 14.2.7 CONSUMER SLEEP SOLUTIONS LLC 290 15 APPENDIX 291 15.1 DISCUSSION GUIDE 291 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 296 15.3 CUSTOMIZATION OPTIONS 298 15.4 RELATED REPORTS 299 15.5 AUTHOR DETAILS 300

TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 32 TABLE 2 SLEEP SOFTWARE MARKET: FACTOR ANALYSIS 42 TABLE 3 SLEEP SOFTWARE MARKET: RISK ASSESSMENT ANALYSIS 47 TABLE 4 SLEEP SOFTWARE MARKET: IMPACT ANALYSIS 58 TABLE 5 ESTIMATED PREVALENCE OF SLEEP APNEA, 2022–2024 60 TABLE 6 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA 61 TABLE 7 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011–2024 65 TABLE 8 SLEEP SOFTWARE MARKET: ROLE IN ECOSYSTEM 76 TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85 TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86 TABLE 12 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 13 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 14 REGULATORY SCENARIO OF NORTH AMERICA 87 TABLE 15 REGULATORY SCENARIO OF EUROPE 89 TABLE 16 REGULATORY SCENARIO OF ASIA PACIFIC 89 TABLE 17 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 91 TABLE 18 REGULATORY SCENARIO OF LATIN AMERICA 91 TABLE 19 AVERAGE SELLING PRICE OF SLEEP APPS, BY REGION (2023) 93 TABLE 20 SLEEP SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS 94 TABLE 21 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE 97 TABLE 22 SLEEP SOFTWARE MARKET: LIST OF PATENTS/PATENT APPLICATIONS 99 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP TWO END USERS (%) 101 TABLE 24 KEY BUYING CRITERIA FOR TOP END USERS 101 TABLE 25 UNMET NEEDS IN SLEEP SOFTWARE MARKET 102 TABLE 26 END-USER EXPECTATIONS IN SLEEP SOFTWARE MARKET 103 TABLE 27 SLEEP SOFTWARE MARKET: KEY CONFERENCES & EVENTS, JANUARY 2025- DECEMBER 2026 104 TABLE 28 SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 116 TABLE 29 SLEEP SOFTWARE MARKET FOR INTEGRATED SOFTWARE, BY REGION, 2022–2030 (USD MILLION) 117 TABLE 30 SLEEP SOFTWARE MARKET FOR STANDALONE SOFTWARE, BY REGION, 2022–2030 (USD MILLION) 118 TABLE 31 SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 120 TABLE 32 SLEEP SOFTWARE MARKET FOR PLATFORMS, BY REGION, 2022–2030 (USD MILLION) 121 TABLE 33 SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 121 TABLE 34 SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 122 TABLE 35 SLEEP SOFTWARE MARKET FOR MOBILE APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 123 TABLE 36 SLEEP SOFTWARE MARKET FOR DESKTOP APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 124 TABLE 37 SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 126 TABLE 38 SLEEP SOFTWARE MARKET FOR SLEEP TRACKING, BY REGION, 2022–2030 (USD MILLION) 127 TABLE 39 SLEEP SOFTWARE MARKET FOR SLEEP IMPROVEMENT, BY REGION, 2022–2030 (USD MILLION) 128 TABLE 40 SLEEP SOFTWARE MARKET FOR SLEEP ANALYSIS, BY REGION, 2022–2030 (USD MILLION) 129 TABLE 41 SLEEP SOFTWARE MARKET FOR SLEEP DISORDER MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 130 TABLE 42 SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 132 TABLE 43 SLEEP SOFTWARE MARKET FOR INSOMNIA, BY REGION, 2022–2030 (USD MILLION) 133 TABLE 44 SLEEP SOFTWARE MARKET FOR SLEEP APNEA, BY REGION, 2022–2030 (USD MILLION) 134 TABLE 45 SLEEP SOFTWARE MARKET FOR GENERAL SLEEP IMPROVEMENT, BY REGION, 2022–2030 (USD MILLION) 135 TABLE 46 SLEEP SOFTWARE MARKET FOR OTHER INDICATIONS, BY REGION, 2022–2030 (USD MILLION) 136 TABLE 47 SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 138 TABLE 48 SLEEP SOFTWARE MARKET FOR ON-PREMISE MODELS, BY REGION, 2022–2030 (USD MILLION) 139 TABLE 49 SLEEP SOFTWARE MARKET FOR CLOUD-BASED MODELS, BY REGION, 2022–2030 (USD MILLION) 140 TABLE 50 SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 142 TABLE 51 SLEEP SOFTWARE MARKET FOR INDIVIDUAL USERS, BY REGION, 2022–2030 (USD MILLION) 143 TABLE 52 SLEEP SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION) 144 TABLE 53 SLEEP SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION) 144 TABLE 54 SLEEP SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 146 TABLE 55 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 148 TABLE 56 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 148 TABLE 57 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 148 TABLE 58 NORTH AMERICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 149 TABLE 59 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 149 TABLE 60 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 149 TABLE 61 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 150 TABLE 62 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 150 TABLE 63 US: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 151 TABLE 64 US: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 151 TABLE 65 US: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 151 TABLE 66 US: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 152 TABLE 67 US: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 152 TABLE 68 US: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 152 TABLE 69 US: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 153 TABLE 70 CANADA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 153 TABLE 71 CANADA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 154 TABLE 72 CANADA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 154 TABLE 73 CANADA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 154 TABLE 74 CANADA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 155 TABLE 75 CANADA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 155 TABLE 76 CANADA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 155 TABLE 77 EUROPE: SLEEP SOFTWARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 156 TABLE 78 EUROPE: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 157 TABLE 79 EUROPE: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 157 TABLE 80 EUROPE: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 157 TABLE 81 EUROPE: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 158 TABLE 82 EUROPE: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 158 TABLE 83 EUROPE: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 158 TABLE 84 EUROPE: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 159 TABLE 85 GERMANY: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 159 TABLE 86 GERMANY: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 160 TABLE 87 GERMANY: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 160 TABLE 88 GERMANY: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 160 TABLE 89 GERMANY: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 161 TABLE 90 GERMANY: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 161 TABLE 91 GERMANY: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 161 TABLE 92 UK: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 162 TABLE 93 UK: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 162 TABLE 94 UK: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 163 TABLE 95 UK: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 163 TABLE 96 UK: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 163 TABLE 97 UK: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 164 TABLE 98 UK: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 164 TABLE 99 FRANCE: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 165 TABLE 100 FRANCE: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 165 TABLE 101 FRANCE: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 165 TABLE 102 FRANCE: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 166 TABLE 103 FRANCE: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 166 TABLE 104 FRANCE: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 166 TABLE 105 FRANCE: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 167 TABLE 106 ITALY: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 167 TABLE 107 ITALY: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 168 TABLE 108 ITALY: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 168 TABLE 109 ITALY: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 168 TABLE 110 ITALY: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 169 TABLE 111 ITALY: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 169 TABLE 112 ITALY: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 169 TABLE 113 SPAIN: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 170 TABLE 114 SPAIN: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 170 TABLE 115 SPAIN: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 171 TABLE 116 SPAIN: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 171 TABLE 117 SPAIN: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 171 TABLE 118 SPAIN: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 172 TABLE 119 SPAIN: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 172 TABLE 120 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 173 TABLE 121 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 173 TABLE 122 REST OF EUROPE: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 173 TABLE 123 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 174 TABLE 124 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 174 TABLE 125 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 174 TABLE 126 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 175 TABLE 127 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 176 TABLE 128 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 177 TABLE 129 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 177 TABLE 130 ASIA PACIFIC: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 177 TABLE 131 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 178 TABLE 132 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 178 TABLE 133 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 178 TABLE 134 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 179 TABLE 135 CHINA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 179 TABLE 136 CHINA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 180 TABLE 137 CHINA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 180 TABLE 138 CHINA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 180 TABLE 139 CHINA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 181 TABLE 140 CHINA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 181 TABLE 141 CHINA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 181 TABLE 142 INDIA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 182 TABLE 143 INDIA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 183 TABLE 144 INDIA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 183 TABLE 145 INDIA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 183 TABLE 146 INDIA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 184 TABLE 147 INDIA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 184 TABLE 148 INDIA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 184 TABLE 149 JAPAN: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 185 TABLE 150 JAPAN: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 185 TABLE 151 JAPAN: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 186 TABLE 152 JAPAN: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 186 TABLE 153 JAPAN: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 186 TABLE 154 JAPAN: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 187 TABLE 155 JAPAN: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 187 TABLE 156 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 188 TABLE 157 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 188 TABLE 158 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 188 TABLE 159 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 189 TABLE 160 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 189 TABLE 161 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 189 TABLE 162 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 190 TABLE 163 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 190 TABLE 164 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 191 TABLE 165 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 191 TABLE 166 LATIN AMERICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 191 TABLE 167 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 192 TABLE 168 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 192 TABLE 169 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 192 TABLE 170 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 193 TABLE 171 BRAZIL: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 193 TABLE 172 BRAZIL: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 194 TABLE 173 BRAZIL: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 194 TABLE 174 BRAZIL: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 194 TABLE 175 BRAZIL: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 195 TABLE 176 BRAZIL: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 195 TABLE 177 BRAZIL: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 195 TABLE 178 MEXICO: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 196 TABLE 179 MEXICO: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 196 TABLE 180 MEXICO: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 197 TABLE 181 MEXICO: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 197 TABLE 182 MEXICO: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 197 TABLE 183 MEXICO: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 198 TABLE 184 MEXICO: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 198 TABLE 185 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 199 TABLE 186 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 199 TABLE 187 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 199 TABLE 188 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 200 TABLE 189 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 200 TABLE 190 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 200 TABLE 191 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 201 TABLE 192 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 201 TABLE 193 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 202 TABLE 194 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 202 TABLE 195 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 202 TABLE 196 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 203 TABLE 197 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 203 TABLE 198 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 203 TABLE 199 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 204 TABLE 200 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 204 TABLE 201 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 205 TABLE 202 GCC COUNTRIES: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 205 TABLE 203 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 205 TABLE 204 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 206 TABLE 205 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 206 TABLE 206 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 206 TABLE 207 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 207 TABLE 208 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 207 TABLE 209 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 208 TABLE 210 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 208 TABLE 211 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022–2030 (USD MILLION) 208 TABLE 212 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 209 TABLE 213 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY END USER, 2022–2030 (USD MILLION) 209 TABLE 214 SLEEP SOFTWARE MARKET: OVERVIEW OF STRATEGIES DEPLOYED KEY PLAYERS, JANUARY 2021–JANUARY 2025 210 TABLE 215 SLEEP SOFTWARE MARKET: DEGREE OF COMPETITION 214 TABLE 216 SLEEP SOFTWARE MARKET: REGION FOOTPRINT 219 TABLE 217 SLEEP SOFTWARE MARKET: TYPE FOOTPRINT 220 TABLE 218 SLEEP SOFTWARE MARKET: OFFERING FOOTPRINT 221 TABLE 219 SLEEP SOFTWARE MARKET: FUNCTION FOOTPRINT 222 TABLE 220 SLEEP SOFTWARE MARKET: INDICATION FOOTPRINT 223 TABLE 221 SLEEP SOFTWARE MARKET: DEPLOYMENT FOOTPRINT 224 TABLE 222 SLEEP SOFTWARE MARKET: END-USER FOOTPRINT 225 TABLE 223 SLEEP SOFTWARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 228 TABLE 224 SLEEP SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION 229 TABLE 225 SLEEP SOFTWARE MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JANUARY 2025 232 TABLE 226 SLEEP SOFTWARE MARKET: DEALS, JANUARY 2021–JANUARY 2025 232 TABLE 227 SLEEP SOFTWARE MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025 233 TABLE 228 SLEEP SOFTWARE MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 234 TABLE 229 CALM: COMPANY OVERVIEW 235 TABLE 230 CALM: SOLUTIONS OFFERED 236 TABLE 231 CALM: DEALS, JANUARY 2021–JANUARY 2025 236 TABLE 232 HEADSPACE INC.: COMPANY OVERVIEW 238 TABLE 233 HEADSPACE INC.: SOLUTIONS OFFERED 238 TABLE 234 HEADSPACE INC.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 239 TABLE 235 HEADSPACE INC.: DEALS, JANUARY 2021–JANUARY 2025 239 TABLE 236 HEADSPACE INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 240 TABLE 237 RESMED: COMPANY OVERVIEW 241 TABLE 238 RESMED: SOLUTIONS OFFERED 242 TABLE 239 RESMED: PRODUCT ENHANCEMENTS, JANUARY 2021–JANUARY 2025 243 TABLE 240 RESMED: DEALS, JANUARY 2021–JANUARY 2025 244 TABLE 241 RESMED: EXPANSIONS, JANUARY 2021–JANUARY 2025 245 TABLE 242 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 246 TABLE 243 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED 248 TABLE 244 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 250 TABLE 245 INSPIRE MEDICAL SYSTEMS, INC.: SOLUTIONS OFFERED 251 TABLE 246 CADWELL INDUSTRIES INC.: COMPANY OVERVIEW 252 TABLE 247 CADWELL INDUSTRIES INC.: SOLUTIONS OFFERED 252 TABLE 248 CADWELL INDUSTRIES INC.: DEALS, JANUARY 2021–JANUARY 2025 253 TABLE 249 COMPUMEDICS LIMITED: COMPANY OVERVIEW 254 TABLE 250 COMPUMEDICS LIMITED: SOLUTIONS OFFERED 255 TABLE 251 NEUROVIRTUAL: COMPANY OVERVIEW 256 TABLE 252 NEUROVIRTUAL: SOLUTIONS OFFERED 256 TABLE 253 NEUROVIRTUAL: EXPANSIONS, JANUARY 2021–JANUARY 2025 257 TABLE 254 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 258 TABLE 255 NIHON KOHDEN CORPORATION: SOLUTIONS OFFERED 259 TABLE 256 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 260 TABLE 257 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2021–JANUARY 2025 260 TABLE 258 NOX MEDICAL: COMPANY OVERVIEW 261 TABLE 259 NOX MEDICAL: SOLUTIONS OFFERED 261 TABLE 260 NOX MEDICAL: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JANUARY 2025 262 TABLE 261 NATUS MEDICAL INCORPORATED: COMPANY OVERVIEW 263 TABLE 262 NATUS MEDICAL INCORPORATED: SOLUTIONS OFFERED 263 TABLE 263 NATUS MEDICAL INCORPORATED: DEALS, JANUARY 2021–JANUARY 2025 264 TABLE 264 RXNT: COMPANY OVERVIEW 265 TABLE 265 RXNT: SOLUTIONS OFFERED 265 TABLE 266 RXNT: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 266 TABLE 267 CLEVELAND MEDICAL DEVICES INC.: COMPANY OVERVIEW 267 TABLE 268 CLEVELAND MEDICAL DEVICES INC.: SOLUTIONS OFFERED 267 TABLE 269 CLEVELAND MEDICAL DEVICES INC.: PRODUCT ENHANCEMENTS, JANUARY 2021–JANUARY 2025 268 TABLE 270 SOMNOMEDICS AG: COMPANY OVERVIEW 269 TABLE 271 SOMNOMEDICS AG: SOLUTIONS OFFERED 269 TABLE 272 SOMNOMEDICS AG: DEALS, JANUARY 2021–JANUARY 2025 270 TABLE 273 CIDELEC: COMPANY OVERVIEW 271 TABLE 274 CIDELEC: SOLUTIONS OFFERED 271 TABLE 275 SLEEP CYCLE: COMPANY OVERVIEW 272 TABLE 276 SLEEP CYCLE: SOLUTIONS OFFERED 273 TABLE 277 SLEEP CYCLE: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 273 TABLE 278 SLEEP CYCLE: DEALS, JANUARY 2021–JANUARY 2025 274 TABLE 279 LÖWENSTEIN MEDICAL SE & CO. KG: COMPANY OVERVIEW 275 TABLE 280 LÖWENSTEIN MEDICAL SE & CO. KG: SOLUTIONS OFFERED 275 TABLE 281 CAMNTECH LTD.: COMPANY OVERVIEW 277 TABLE 282 CAMNTECH LTD.: SOLUTIONS OFFERED 277 TABLE 283 CAMNTECH LTD.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 278 TABLE 284 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW 279 TABLE 285 FISHER & PAYKEL HEALTHCARE LIMITED: SOLUTIONS OFFERED 280 TABLE 286 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 281 TABLE 287 FISHER & PAYKEL HEALTHCARE LIMITED: EXPANSIONS, JANUARY 2021–JANUARY 2025 281 TABLE 288 BIOSERENITY: COMPANY OVERVIEW 282 TABLE 289 BIOSERENITY: SOLUTIONS OFFERED 282 TABLE 290 BIOSERENITY: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 283 TABLE 291 VYAIRE MEDICAL, INC.: COMPANY OVERVIEW 284 TABLE 292 VYAIRE MEDICAL, INC.: SOLUTIONS OFFERED 284 TABLE 293 HONEYNAPS: COMPANY OVERVIEW 285 TABLE 294 SLEEPIMAGE: COMPANY OVERVIEW 286 TABLE 295 SLEEP RESET: COMPANY OVERVIEW 287 TABLE 296 BIGHEALTH: COMPANY OVERVIEW 288 TABLE 297 BODYMATTER, INC.: COMPANY OVERVIEW 289 TABLE 298 NEYBOX DIGITAL LTD.: COMPANY OVERVIEW 289 TABLE 299 CONSUMER SLEEP SOLUTIONS LLC: COMPANY OVERVIEW 290 FIGURE 1 MARKETS & REGIONS COVERED 30 FIGURE 2 RESEARCH DESIGN 34 FIGURE 3 PRIMARY SOURCES 37 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 38 FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 39 FIGURE 6 SUPPLY-SIDE MARKET ESTIMATION 40 FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030) 43 FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 44 FIGURE 9 TOP-DOWN APPROACH 44 FIGURE 10 DATA TRIANGULATION METHODOLOGY 45 FIGURE 11 SLEEP SOFTWARE MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION) 49 FIGURE 12 SLEEP SOFTWARE MARKET, BY OFFERING, 2024 VS. 2030 (USD MILLION) 49 FIGURE 13 SLEEP SOFTWARE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION) 50 FIGURE 14 SLEEP SOFTWARE MARKET, BY INDICATION, 2024 VS. 2030 (USD MILLION) 50 FIGURE 15 SLEEP SOFTWARE MARKET, BY DEPLOYMENT, 2024 VS. 2030 (USD MILLION) 51 FIGURE 16 SLEEP SOFTWARE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 52 FIGURE 17 SLEEP SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT 53 FIGURE 18 AWARENESS REGARDING SLEEP-RELATED DISORDERS AND HIGH RETURNS ON INVESTMENT FOR SLEEP SOFTWARE SOLUTIONS TO DRIVE MARKET GROWTH 54 FIGURE 19 INDIVIDUAL USERS IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 55 FIGURE 20 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 56 FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES THAN DEVELOPED ECONOMIES DURING FORECAST PERIOD 56 FIGURE 22 SLEEP SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57 FIGURE 23 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024 63 FIGURE 24 MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR IN US, 2009–2024 64 FIGURE 25 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023 64 FIGURE 26 WORLD POPULATION COVERAGE, BY TYPE OF MOBILE NETWORK, 2015–2023 68 FIGURE 27 REGIONAL POPULATION COVERAGE, BY TYPE OF MOBILE NETWORK, 2023 69 FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN SLEEP SOFTWARE MARKET 72 FIGURE 29 SLEEP SOFTWARE MARKET: ECOSYSTEM ANALYSIS 75 FIGURE 30 SLEEP SOFTWARE MARKET: SUPPLY CHAIN ANALYSIS 77 FIGURE 31 AVERAGE SELLING PRICE OF SLEEP APPS, BY KEY PLAYER (2023) 92 FIGURE 32 SLEEP SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS 94 FIGURE 33 PATENT PUBLICATION TRENDS IN SLEEP SOFTWARE MARKET, 2015–2024 96 FIGURE 34 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE PATENTS (JANUARY 2015–DECEMBER 2024) 97 FIGURE 35 MAJOR PATENTS IN SLEEP SOFTWARE MARKET (JANUARY 2015–DECEMBER 2024) 98 FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 100 FIGURE 37 KEY BUYING CRITERIA FOR TOP END USERS 101 FIGURE 38 RECENT FUNDING OF PLAYERS IN SLEEP SOFTWARE MARKET 106 FIGURE 39 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING SLEEP SOFTWARE ACROSS INDUSTRIES 108 FIGURE 40 NORTH AMERICA: SLEEP SOFTWARE MARKET SNAPSHOT 147 FIGURE 41 ASIA PACIFIC: SLEEP SOFTWARE MARKET SNAPSHOT 176 FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN SLEEP SOFTWARE MARKET, 2019–2023 (USD MILLION) 213 FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SLEEP SOFTWARE MARKET (2023) 214 FIGURE 44 SLEEP SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 217 FIGURE 45 SLEEP SOFTWARE MARKET: COMPANY FOOTPRINT 218 FIGURE 46 SLEEP SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 227 FIGURE 47 EV/EBITDA OF KEY SLEEP SOFTWARE VENDORS (2025) 229 FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF SLEEP SOFTWARE VENDORS (2024) 230 FIGURE 49 SLEEP SOFTWARE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 231 FIGURE 50 RESMED: COMPANY SNAPSHOT 242 FIGURE 51 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 247 FIGURE 52 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT 250 FIGURE 53 COMPUMEDICS LIMITED: COMPANY SNAPSHOT 254 FIGURE 54 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 259 FIGURE 55 SLEEP CYCLE: COMPANY SNAPSHOT 272 FIGURE 56 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT 280

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Sleep Software Market by Function (Sleep Tracking, Analysis, Disorder Management, Improvement), Indication (Insomnia, Sleep Apnea), Offering (Platforms, Apps (Mobile)), End-user (Providers, Individual), Deployment, Type, & Region - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（醫療與生命科學）